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Abstract
Background: Exploratory factor analysis is a commonly used statistical technique in metabolic syndrome research to
uncover latent structure amongst metabolic variables. The application of factor analysis requires methodological decisions
that reflect the hypothesis of the metabolic syndrome construct. These decisions often raise the complexity of the
interpretation from the output. We propose two alternative techniques developed from cluster analysis which can achieve a
clinically relevant structure, whilst maintaining intuitive advantages of clustering methodology.
Methods: Two advanced techniques of clustering in the VARCLUS and matroid methods are discussed and implemented on
a metabolic syndrome data set to analyze the structure of ten metabolic risk factors. The subjects were selected from the
normative aging study based in Boston, Massachusetts. The sample included a total of 847 men aged between 21 and 81
years who provided complete data on selected risk factors during the period 1987 to 1991.
Results: Four core components were identified by the clustering methods. These are labelled obesity, lipids, insulin
resistance and blood pressure. The exploratory factor analysis with oblique rotation suggested an overlap of the loadings
identified on the insulin resistance and obesity factors. The VARCLUS and matroid analyses separated these components
and were able to demonstrate associations between individual risk factors.
Conclusions: An oblique rotation can be selected to reflect the clinical concept of a single underlying syndrome, however
the results are often difficult to interpret. Factor loadings must be considered along with correlations between the factors.
The correlated components produced by the VARCLUS and matroid analyses are not overlapped, which allows for a simpler
application of the methodologies and interpretation of the results. These techniques encourage consistency in the
interpretation whilst remaining faithful to the construct under study.
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Introduction
Metabolic syndrome (MetS) defines a clustering of risk factors
that act as an indicator for many chronic diseases such as kidney
disease [1,2], cardiovascular disease and type 2 diabetes mellitus [3–
5], however the components of MetS are still controversial [6]. In
recent literature, exploratory and confirmatory factor analyses have
been used to test the latent structure of MetS, and regression
modelling is used to test the relation between chronic diseases and
MetS components [7,8]. Whilst some exploratory analyses, such as
principal component analysis (PCA) and exploratory factor analysis
(EFA), can provide an insight into the structure of the data, the
results are often difficult to interpret and methodological decisions
are rarely justified in the application of the techniques. Discussion
regarding the misuse of factor analysis in psychological research is
quite common [9–11], however many of the same issues are rarely
highlighted in the clinical and epidemiological literature.
Definitions of MetS have been proposed by a number of leading
health bodies [12,13]. Two of the most commonly accepted are
those of the World Health Organization (WHO) and the National
Cholesterol Education Adult Treatment Panel III (ATP III) [14].
A study by Ford et al. [15] compared the prevalence of MetS using
these two definitions. In a nationally representative sample of
8,608 Americans, they found disagreement amongst 13.8% of the
subjects classified as suffering from MetS when comparing these
criteria. The variation in definitions highlights an uncertainty in
the underlying mechanisms. This ultimately leads to confusion
over the diagnosis of such a syndrome. The clustering amongst the
metabolic risk factors should stimulate research into a further
understanding of their inter-relationships, but the use of existing
definitions should be implemented with caution [16,17]. The study
by Ford et al. further highlighted differences amongst subgroups of
the population (e.g. 16.5% of African-American men were
diagnosed as suffering from MetS using the ATP III criteria,
whilst 24.9% were diagnosed using the WHO criteria). Evidence
suggests that the form of the hypothesized syndrome is not
consistent across populations [14,18]. We require methodology
that is flexible to accommodate this change, but remains able to
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identify biological consistency when it is present across subgroups
and over time.
The clinical relevance should be the primary aim for selecting
statistical methodology and deciding its application. When the
conclusions of an explorative study are so heavily dependent on
the application of the method, the reasoning behind each
methodological decision must have a strong theoretical basis
[9,11]. The ease and speed of performing an EFA in modern
statistical software has encouraged widespread use of the
methodology, but this should only serve to heighten the caution
adopted with the results. Despite attempts to warn against the
dangers of misguided decision making in factor analysis, they are
still commonly found in the literature [9,19,20]. There are also
very few guidelines for researchers undertaking an EFA in applied
research. Default software options set up by some software
packages such as PCA [21] for factor extraction, the Guttman-
Kaiser criterion [22,23] to determine the number of factors to
extract and the varimax (orthogonal) rotation [24] to obtain an
interpretable solution, were often adopted with little or no
justification to the clinical application. The same decisions as
previous studies may be selected to ensure comparability, or
researchers are simply ill-informed of the effects of their
(potentially default) decisions [9].
For the study of MetS, the methodological decisions used in the
application of EFA rarely appear to reflect the clinical hypothesis
of the concept. It is the methodological decision making that is
crucial to ensure that the analysis relates to the construct under
study. The main restriction in an explorative MetS study is that to
achieve such a structure, the complexity of the decision making
increases and the interpretation of the results often becomes
difficult. In this study, we discuss these methodological decisions
in relation to current MetS theory and present two novel
applications of clustering methodology. The aim of this study is to
encourage a consistently high contextual validity (in parallel with
appropriate methodological decisions in EFA), without the need
to increase the complexity in the application of statistical me-
thods. The results of the methods performed on a selection of
metabolic risk factors demonstrate a promising agreement to the
general structure of the construct, whilst also providing additional
insights into the complex pathways present amongst the risk
factors.
Methods
2.1 Study Subjects
We analyzed cross-sectional data from a study by Shen et al.
[25]. In short, the data was collected from 847 men aged between
21 and 81 years in the ‘Normative aging study’ (NAS). The
ongoing study was based in Boston, Massachusetts and included a
total of 2,280 predominantly white community-dwelling males
(with a mean age of 61 years). The subjects were selected from an
original 6,000 applicants who were screened at entry for existing
health conditions. Those suffering from known chronic diseases,
such as cardiovascular disease and type 2 diabetes mellitus, were
excluded from the study. The 847 subjects selected for the
application were those examined between 1987 and 1991 who
provided complete data for the following covariates: fasting insulin
(Ins), postchallenge insulin (PCIns), fasting glucose (Glu), postchal-
lenge glucose (PCGlu), body mass index (BMI), waist/hip ratio
(WHR), high density lipoprotein cholesterol (HDL), triglycerides
(Trig), systolic blood pressure (SBP) and diastolic blood pressure
(DBP). The method of data collection and the description of risk
factors in the NAS have been presented in previous papers
[25,26].
2.2 Statistical Analysis
The analysis by Shen et al. [25] considered evidence from a
range of exploratory studies to construct three hypothetical models
for the structure of MetS. The evidence was gained from the use of
EFA and in particular PCA. The subjective nature of factor
analysis as an exploratory technique is highlighted by Shen. The
series of factor structures underline the range of potential
hypotheses and heuristic interpretations. Instead, a confirmatory
factor analysis (CFA) is employed based on the results of the
previous EFA studies and biological knowledge. The use of CFA is
repeated in Shen et al. [18] to examine the structure of MetS
across sex and ethnic groups, citing the conflicting and inconsistent
results of EFA studies as motivation for choosing the methodology.
A ‘true’ factor analysis method (as opposed to a PCA) is based
on the common factor model [27] – that assumes the observed
covariation amongst the predictors is being caused by one or more
latent factors. For example, in MetS data the observed variables
are entered as ‘‘symptoms’’ exhibited by the patient. When an
EFA is performed on the data, the researcher interprets that the
factors extracted represent a ‘‘syndrome’’ as collectively they
characterize some unobserved medical condition. When applying
the methodology, the user must select the number of factors to
retain and may specify a rotational method as a secondary step to
obtain an interpretable solution. In addition, an arbitrary
threshold may be applied to determine ‘significant’ loadings to
interpret the meaning of the factors.
We consider an alternative explorative view provided from
clustering methodology. The interpretation of observed covariates
rather than abstract factors should make variable clustering
techniques an attractive option in applied research. Problems
associated with a ‘heuristic’ reading of components in factor
analysis are simplified by considering distinct non-overlapping
clusters, allowing for datasets with a large numbers of variables to
be analyzed with substantially less difficulty and improved
consistency [28,29]. Hierarchical clustering allows for images to
be constructed to aid with interpretation and effectively guarantees
a ‘simple structure’ [30].
2.2.1 The VARCLUS approach. An issue that hinders
traditional cluster analysis as a technique to identifying latent
structures is that the analysis is based on pair-wise dependencies.
This means that underlying relationships amongst covariates may
not be identified - for example, a variable Z can be approximated
as a function of X and Y, but none of the variables is involved in a
pair-wise near dependency. An alternative approach is to utilize
factor analytic methods in a hierarchical clustering framework -
labelled the VARCLUS approach [31]. To identify dependencies,
the process builds clusters of covariates around latent components.
The technique computes the first principal component of each
cluster (beginning at a cluster containing all the covariates) and
iteratively splits them into two separate clusters based on some pre-
defined criteria. The user may suggest that if the second largest
eigenvalue is greater than some given threshold value, this
demonstrates evidence of an additional dimension. Alternatively,
they may pre-define the number of clusters to extract based on
external biological evidence. The variables are assigned to the
cluster in which they demonstrate the highest squared correlation
(i.e. R2) and later reassigned if the variance explained increases by
including the covariate in another cluster. This approach ensures
that the orthogonality assumption of PCA is relaxed. The com-
ponents obtained are naturally oblique and therefore referred to
as cluster components rather than principal components. This
feature is beneficial to MetS study with inter-correlated clusters
more likely to reflect the hypothesis of a single unified syndrome
[25].
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The VARCLUS process compromises on the maximal variance
extraction of a PCA to maintain the intuitive advantages of
clustering observed covariates. The process of directly fitting
assigned labels for variables to 1 or higher dimensional clusters is
labelled a ‘hard’ clustering technique. This has the advantage of
retaining some of the interpretive power of a cluster analysis (in
producing clusters with observed covariates), whilst making use of
a components analysis to identify latent constructs within a
dataset. In addition, the VARCLUS procedure in SAS provides a
coefficient of determination for each variable within its own cluster
(i.e. the degree to which the covariate is explained by the
remaining covariates in the cluster - R2own) and also with the
nearest cluster in which it demonstrates the greatest R2 (labelled
R2nearest). If clusters are well defined, the degree of association is
maximal for variables within the same cluster and minimal to
those in others. A ratio value 1{ R2own

R2nearest
 
is provided to
demonstrate this feature. These values are particularly useful when
considered with the limitations associated with ordinary ‘hard’ (i.e.
non-overlapping) clustering procedures. Whilst the clusters
produced from a VARCLUS analysis are of the form of a ‘hard’
clustering method, the R2 values indicate the strength of the
cluster membership for each variable.
2.2.2 The Matroid Approach. It is realistic for the user not
to expect predictors in a complicated structure such as MetS to
naturally form ‘neat’ hierarchical groups (i.e. a ‘simple’ structure);
rather, we force them to be with ‘hard’ clustering techniques (such
as the VARCLUS). This form of clustering is useful because of the
benefits to interpretation it brings, but with it we bypass some of
the subtleties in the relations that EFA attempts to identify. The
VARCLUS looks to avoid this limitation by providing R2
statistics. This is particularly useful as in a complicated structure,
such as MetS, it would seem likely that the predictors will be
involved in multiple dependencies. We propose another method in
the matroid approach that could provide a compromise, whilst
retaining the interpretational benefits associated with producing
distinct non-overlapping clusters. Suggested by Greene [32], the
method draws from existing successful ideas in the field of
collinearity diagnostics and cluster analysis, whilst also introducing
favourable properties of matroids, which have previously been
confined largely to theoretical work.
The matroid approach works on the collection of all subsets of
variables, rather than considering the entire set at once. Initially,
data are divided into all possible rearrangements of covariates and
these are assigned to either a ‘dependent’ or ‘independent’ group
using a suitable index. For example, a ‘dependent’ subset may be
defined by the smallest eigenvalue being lower than a particular
threshold. Any remaining clusters of variables are labelled
‘independent’. The group of dependent subsets are then converted
into a matroid structure to ensure that they demonstrate a
combinatorial arrangement corresponding to linear relationships
among a collection of variables (See Welsh [33] for the axioms that
define a matroid). The challenge with the matroid technique is
how to convey the information of all the dependent subsets in the
simplest form to the user. Greene suggests extracting a
combinatorial group from those selected known as flats. A rank-j
flat is a maximal set of covariates that can be represented by a j-
dimensional projection [34]. In other words, if we are unable to
add another covariate to the subset without increasing its rank (i.e.
dimensionality), then it is labelled a flat. The flats ensure that every
covariate involved in a dependency is identified. In Greene’s
approach we retain the general concept of ‘hard’ clustering, but we
produce a dependency structure for a range of threshold values
(i.e. at different strengths of dependency). A cluster is not defined
only if it is uni-dimensional (as it would be for ordinary clustering),
but if it exhibits a near dependency falling close to any lower
dimensional subspace. The dimensionality of the flat determines its
rank. A labelled Hasse diagram (LHD) is used to display the flats of
the matroid (see figure 1). Each threshold produces its own
hierarchical structure containing dependencies of any rank. Flats
are displayed as ellipses and those variables presenting no
dependency as squares (i.e. independent). The rank of each subset
is illustrated on the left of the LHD and the flats joined with lines
are to show the sources of any dependency. An R2 measure is
displayed in brackets alongside each variable to demonstrate the fit
of the variable (determined by squared correlation with the
remaining covariates) to the flat in which it is assigned.
Results
3.1 EFA
To gain a solution using EFA we select a principal factor
analysis (PFA) method which is based on the common factor
model. The intention of employing this model is to capture the
clinical notion of an underlying construct amongst the manifest
variables – as hypothesized by the MetS concept [6]. To
determine the number of components to retain, statistical methods
such as the Guttman-Kaiser criterion and parallel analysis suggest
the presence of four and five factors in the model respectively.
However, biological evidence should be utilized when possible to
drive the analysis. Studies analysing similar risk factors of MetS
(although on a different population) have proposed a four factor
structure and so this will form the basis of our EFA model [35,36].
This will also provide a direct comparison with the structures
investigated in the original CFA analysis by Shen et al. An oblique
‘promax’ rotation [37] (i.e. correlated factors) is used to assess the
hypothesis of a single unified MetS construct. The ‘significant’
loadings (highlighted in bold) have been selected using an arbitrary
threshold of 0.3. This is suggested by Child [38] for data with
sample size equal to or greater than 100 – however, this popular
threshold is recommended only as a guide. Therefore, we present
all the values for the benefit of the reader. The oblique ‘promax’
rotation has achieved close to a ‘simple structure’ with ‘blood
pressure’ and ‘lipid’ factors clearly defined as factors 3 and 4
respectively (see table 1). Whilst the ‘blood pressure’ factor
demonstrates moderate correlations with other factors (see
table 2), there appears more complex inter-relationships amongst
the remaining three factors. The insulin covariates (Ins, PCIns) load
‘significantly’ along with BMI and WHR on factor 1, whilst PCIns
also loads ‘significantly’ on factor 2 along with the glucose
covariates (Glu, PCGlu). There are also high correlations between
factor 1 and each of the remaining factors, suggesting that obesity
may be a central underlying factor of the MetS construct.
3.2 VARCLUS
The ‘PROC VARCLUS’ algorithm in SAS is an example of the
VARCLUS procedure described in section 2.2.1 and has been
used in the following application. To ensure comparability, we
specified a maximum cluster option of four cluster components
and a PCA extraction to construct latent clusters. The cluster
dendrogram is illustrated in figure 2. The four cluster components
listed in table 3 appear to relate to ‘lipid’ (cluster 1), ‘blood
pressure’ (cluster 2), ‘insulin resistance’ (cluster 3) and ‘obesity’
(cluster 4). This is analogous to the CFA structures specified by
model 1 and model 3 in Shen et al. [25]. The low R2 ratios
1{ R2own

R2nearest
 
for clusters 1, 2 and 4 indicate that the cluster
components are ‘well formed’. However, the ‘insulin resistance’
cluster component exhibits high values for the R2 ratio for Ins and
Glu risk factors. The cluster structure analysis in table 4 suggests
Exploratory Analysis of Metabolic Syndrome
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that Ins in particular loads highly on the ‘obesity’ component and
BMI similarly on the ‘insulin resistance’ component (note that
‘loadings’ demonstrate the correlation between the covariate and
the cluster component). This is further evidenced by the
correlation between the ‘insulin resistance’ and ‘obesity’ cluster
components shown in table 5.
The cluster structure explains 68% of the total variation (see
table 6) and reduces the dimension of the variables from 10 to 4.
This simple example has allowed us to gain an immediate insight
into the cluster structure, whilst still observing that the variables
are likely to be involved in multiple mechanisms. The cluster
structure and R2 statistics indicate which covariates appear ‘least
comfortable’ within the clusters and with which others they are
related to. For instance, Glu has a high R2 ratio (0.6), but it is not
highly related to another cluster (i.e. low R2own) - the variable itself
is not explained well by its own cluster. This adds further strength
to the involvement of Ins and PCIns in other dependencies; namely
a relationship between BMI and the insulin risk factors (as
suggested in the EFA analysis). Also, HDL again demonstrates a
high loading on the ‘insulin resistance’ cluster component. The
analysis provides further evidence to the independence of the
‘blood pressure’ component (i.e. cluster 4).
3.3 The Matroid Approach
We coded the procedure for the matroid technique using the
free software package R [39]. The method has been applied to
data using a criteria based on R2; If a subset displayed an R2
higher than the threshold value (illustrated on the left of the LHD)
it is assigned dependent. The matroid LHD is displayed in figure 3.
Figure 1. An example labelled Hasse diagram. The ellipses in the labelled Hasse diagram (LHD) demonstrate near dependencies and any
variables not involved in a linear dependency are displayed as squares. The rank of each subset (illustrated on the left of the LHD) demonstrates the
dimensionality of the flat. Lines between objects are used to show the sources of any dependency. An R2 measure is displayed in brackets alongside
each variable to demonstrate the fit to the flat in which it is assigned. Abbreviations: Fasting insulin (Ins), postchallenge insulin (PCIns), fasting glucose
(Glu), postchallenge glucose (PCGlu), body mass index (BMI), waist/hip ratio (WHR), high density lipoprotein cholesterol (HDL), triglycerides (Trig),
systolic blood pressure (SBP), diastolic blood pressure (DBP).
doi:10.1371/journal.pone.0034410.g001
Table 1. The factor pattern from an exploratory factor
analysis.
Loadings
Factor 1 Factor 2 Factor 3 Factor 4 Communality
Ins 0.70 0.11 20.01 20.05 0.55
PCIns 0.52 0.37 0.04 20.03 0.62
Glu 20.06 0.63 20.08 0.06 0.36
PCGlu 20.03 0.77 0.04 0 0.58
BMI 0.63 20.08 0 0.09 0.4
WHR 0.53 20.13 0 0.12 0.29
Trig 20.08 0 0.06 20.57 0.36
HDL 0.07 0.09 0.08 0.55 0.41
SBP 20.06 0.08 0.69 0.01 0.48
DBP 0.06 20.11 0.69 20.01 0.47
A principal factor analysis is selected with four factors retained and an oblique
promax rotation used. Significance is highlighted in bold text and is determined
by a factor loading .0.3. The significant loadings suggest a blood pressure
factor (factor 3) and a lipid factor (factor 4). Factor 1 and factor 2 demonstrate
some overlap with PCIns loading significantly on each. Abbreviation: Fasting
insulin (Ins), postchallenge insulin (PCIns), fasting glucose (Glu), postchallenge
glucose (PCGlu), body mass index (BMI), waist/hip ratio (WHR), high density
lipoprotein cholesterol (HDL), triglycerides (Trig), systolic blood pressure (SBP),
diastolic blood pressure (DBP).
doi:10.1371/journal.pone.0034410.t001
Table 2. Inter-factor correlations from the exploratory factor
analysis solution.
Factor 1 Factor 2 Factor 3 Factor 4
Factor 1 1 0.54 0.36 0.49
Factor 2 0.54 1 0.27 0.27
Factor 3 0.36 0.27 1 0.13
Factor 4 0.49 0.27 0.13 1
An oblique solution produces correlated factors. The inter-factor correlations
demonstrate a high correlation between factor 1 and factor 2 (0.54). There is
also a large correlation between factor 1 and factor 4 (0.49).
doi:10.1371/journal.pone.0034410.t002
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The four component structures identified by Shen et al. [25] and
the VARCLUS approach are consistent with the 0.21 threshold
level of the matroid depiction. In the 0.22 threshold we view an
overhanging flat of rank-2 that links BMI and WHR with the
insulin resistance flat. This was hypothesised in the VARCLUS
example in observing a high correlation between these dependen-
cies and a high loading of the Ins risk factor on the ‘obesity’ cluster
component. Also, in the 0.23 threshold, BMI, HDL and Trig are
linked with ‘insulin resistance’, however WHR is not. This again
appears to agree with the first component of the cluster structure
in the VARCLUS analysis (table 4) and the low communality
estimate of the EFA (table 3). Observing the higher dimensional
flats has added an intuitive description of the ‘fuzzy’ (i.e.
overlapped) structure amongst the risk factors.
Perhaps the most important feature of the matroid technique is
found with the higher ranked subsets extracted at particular
thresholds. The intention of these is to identify subtle relationships
amongst the uni-dimensional (i.e. rank-1) flats. For instance, at the
0.23 threshold, there is a rank-3 flat containing {Ins, PCIns, Glu,
PCGlu, BMI, HDL, Trig} that is not identified elsewhere in the
clustering. This may indicate a potential mechanism amongst the
variables. The advantage here is that we retain the interpretive
benefits of producing distinct non-overlapping clusters whilst
identifying relationships potentially masked by stronger depen-
dencies at higher thresholds. The flats in this example appear to
demonstrate that the predictors (aside from SBP, DBP) are ‘fuzzy’
in nature (i.e. naturally overlapped). Overhanging dependencies of
higher rank may suggest a possible hierarchical structure and
could be viewed as evidence to support a concept such as MetS.
Discussion
The methods compared in this study each provide an
alternative approach to identifying and visualizing the structure
of the MetS risk factors. The variability between the methods is
expected as they are based on different statistical philosophies to
grouping covariates. An EFA seeks to optimize the fit of the data to
a common factor model in which observed variables are expressed
as a k-dimensional collection of ‘‘common factors’’, when k factors
are retained. An oblique rotation is employed as a secondary step
to provide some indication of the clustering amongst the observed
variables. The identification of such clusters is in general ad hoc and
is not incorporated into the model fitting. In comparison, the
VARCLUS and matroid methods directly seek clusters of
observed covariates in a single step. The role of the VARCLUS
analysis is to identify 1-dimensional clusters of mutually correlated
variables. The matroid approach has a similar goal, but also looks
to identify higher dimensional near dependencies falling close to a
lower dimensional subspace. In VARCLUS a k-dimensional
representation can be selected by the user prior to the analysis,
whilst for a matroid approach the dimensionality is selected at one
of the thresholds post analysis. This selection may utilize external
biological or clinical knowledge. The optimal fit of the data to
common factors in an EFA (or PCA) is sacrificed for the cluster
Figure 2. A dendrogram of the cluster structure produced by VARCLUS. A hierarchical clustering produced from the VARCLUS analysis with
four cluster components selected. Abbreviation: Fasting insulin (Ins), postchallenge insulin (PCIns), fasting glucose (Glu), postchallenge glucose
(PCGlu), body mass index (BMI), waist/hip ratio (WHR), high density lipoprotein cholesterol (HDL), triglycerides (Trig), systolic blood pressure (SBP),
diastolic blood pressure (DBP).
doi:10.1371/journal.pone.0034410.g002
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identification benefits of a VARCLUS or matroid analysis. For
each of these methods the fundamental ideas have been selected to
have a greater clinical relevance to the MetS hypothesis than the
potentially default decisions frequently employed in an EFA.
Whilst in this study the EFA has not produced the same distinct
factors as the cluster components in a VARCLUS or the flats in a
matroid, the results are in agreement over the general structure of
the risk factors. The oblique rotation in the EFA allows for
correlation between the factors to reflect a single underlying
syndrome. This correlation along with the loadings ensures that
any clinical interpretation is likely to be difficult. The ‘lipid’
component (including HDL and Trig) along with the blood
pressure component (including SBP and DBP) are identified in
each approach. When no overlap exists (i.e. variables do not load
‘significantly’ on more than one factor) as in these factors, it is
easier to interpret the correlations between the factors. The
confusion in our example occurs due to the significant loading of
PCIns on the first two factors in the EFA and the correlation
between these factors. The VARCLUS and matroid methods have
instead provided a direct k-dimensional structure for a follow up
CFA if required, but also indicated how stable the clustering is.
The strong association between the risk factors included in the
‘insulin resistance’ and ‘obesity’ factors are clear in each method.
However, the non-overlapping clusters produced by the alterna-
tive techniques allows for a simpler interpretation of the latent
variables.
The aspect that we have focussed on is the use of visual image
and ‘hard’ clustering to simplify the potentially complex
interpretation of an oblique solution. The difficulty with MetS is
that its structure is likely to be hierarchical in nature (from a
statistical perspective). A PCA with default methodological
decisions is unsuitable to match the complexity or concept of this
MetS construct. It may be that a hierarchical or second order
factor analysis could provide an appropriate tool to analyze the
structure of MetS (with the intention to separate ‘broad’ factors
from ‘narrow’ factors). However, it is important to remember the
context in which these methods are to be used. A likely reason that
an oblique EFA or hierarchical factor analysis are rarely used in
Table 3. A table of R2 measures demonstrating the ‘quality’
of each cluster component.
Variable R2own R
2
nearest 1{ R
2
own

R2nearest
 
Cluster 1 Trig 0.735 0.076 0.287
HDL 0.735 0.12 0.301
Cluster 2 SBP 0.785 0.058 0.228
DBP 0.785 0.031 0.222
Cluster 3 Ins 0.542 0.208 0.579
PCIns 0.704 0.149 0.348
Glu 0.42 0.035 0.601
PCGlu 0.624 0.044 0.394
Cluster 4 BMI 0.73 0.17 0.325
WHR 0.73 0.087 0.296
The R2own demonstrate the R
2 of the variable when regressed on the remaining
variables in the cluster to which it is assigned. The R2nearest is the greatest R
2
when the variable is regressed on any other cluster produced in the analysis.
The 1{ R2own

R2nearest
 
is a measure of cluster ‘quality’. When a variable has a
high R2 within its own cluster and low to any other, the variable demonstrates
a strong fit to the cluster in whch it is assigned. Abbreviation: Fasting insulin
(Ins), postchallenge insulin (PCIns), fasting glucose (Glu), postchallenge glucose
(PCGlu), body mass index (BMI), waist/hip ratio (WHR), high density lipoprotein
cholesterol (HDL), triglycerides (Trig), systolic blood pressure (SBP), diastolic
blood pressure (DBP).
doi:10.1371/journal.pone.0034410.t003
Table 4. The correlation (or loading) between each covariate
and the cluster components.
Cluster 1 Cluster 2 Cluster 3 Cluster 4
Ins 20.297 0.192 0.736 0.456
PCIns 20.332 0.226 0.839 0.386
Glu 20.169 0.051 0.648 0.187
PCGlu 20.187 0.169 0.79 0.211
BMI 20.297 0.164 0.412 0.854
WHR 20.268 0.13 0.295 0.854
Trig 0.857 20.017 20.219 20.275
HDL 20.857 0.152 0.346 0.293
SBP 20.099 0.886 0.24 0.129
DBP 20.076 0.886 0.145 0.176
The loadings produced in a VARCLUS analysis are analogous to factor loadings
in a factor analysis. Each loading represents the correlation of the variable with
the cluster component. The loadings of the variables assigned to the cluster
component are highlighted in bold. Abbreviation: Fasting insulin (Ins),
postchallenge insulin (PCIns), fasting glucose (Glu), postchallenge glucose
(PCGlu), body mass index (BMI), waist/hip ratio (WHR), high density lipoprotein
cholesterol (HDL), triglycerides (Trig), systolic blood pressure (SBP), diastolic
blood pressure (DBP).
doi:10.1371/journal.pone.0034410.t004
Table 5. The correlations between cluster components.
Cluster 1 Cluster 2 Cluster 3 Cluster 4
Cluster 1 1 20.099 20.33 20.331
Cluster 2 20.099 1 0.217 0.172
Cluster 3 20.33 0.217 1 0.414
Cluster 4 20.331 0.172 0.414 1
The correlations between cluster components are analogous to inter-cluster
correlations in a factor analysis with oblique rotation. Cluster 3 and cluster 4
demonstrate the strongest correlation (0.414), indicating an association
between obesity and insulin resistance risk factors.
doi:10.1371/journal.pone.0034410.t005
Table 6. A summary of the variance explained by each cluster
component.
Variance
Explained
Proportion
Explained
2nd
Eigenvalue
Cluster 1 1.47 0.785 0.53
Cluster 2 1.57 0.785 0.43
Cluster 3 2.289 0.572 0.933
Cluster 4 1.46 0.73 0.54
Total variance
explained:
6.789 0.679
The 4 cluster components have explained 68% of the total variation in the data.
Cluster 3 explains the largest variation in the data. The proportion explained is
calculated as the total variance of the variables in the cluster divided by the
variance explained. The 2nd eigenvalue indicates that cluster 3 would be the
next to be split if the analysis were to be extended to a 5 cluster solution.
doi:10.1371/journal.pone.0034410.t006
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practice is due to the statistical complexity in the application and
interpretation. Therefore, we remain mindful of this when
promoting methodology such as VARCLUS and matroids to
retain a simpler interpretation, whilst improving the consistency
and appropriateness of the decision making in MetS study. This
will provide a step toward the suitable level of complexity required
to reflect the clinical nature of the MetS construct, without the
difficulties of interpreting an EFA.
Concluding Remarks
In this article we have concentrated on the exploratory
approach. However, when combined with sound prior knowledge,
a CFA can be used effectively to validate potentially complex
structures; it allows for the testing of specific questions about the
nature of the underlying mechanisms [40]. The use of an EFA or
CFA approach should rest on the confidence of the researcher in
the models used. Can we suggest a complete model, or is there
sufficient uncertainty in the population structure that an
explorative approach can relieve? These methods are not separate
entities; they are instead a reflection of our confidence in the ‘a
priori’ knowledge. As such, a considered and justified decision
making process for EFA research can provide a powerful tool in
developing our understanding of the MetS construct in partner-
ship with CFA. Ideally, we would wish MetS research to favour a
CFA approach, however limitations in exploratory techniques (or
their application) suggest that the statistical evidence used to
construct the CFA models may be less than satisfactory. The
criteria for MetS, such as those proposed by the WHO and ATP
III, have been developed to diagnose subjects, whereas the
methods presented in this paper are not intended to form such
criteria. However, the continued use of explorative techniques is of
great importance. If methods such as PCA or EFA fail to reveal an
underlying latent structure, the very existence of MetS becomes
questionable. The intention of developing methodology such as
the VARCLUS and matroid approaches is primarily to encourage
consistency and reproducibility across MetS studies. It is not
possible to judge from the explorative methods which will provide
the ‘correct’ structure, and there may never be such a structure.
Exploratory approaches should instead be valued on which yield
the more useful results in terms of understanding the complex
inter-relationships amongst the metabolic variables.
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